Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Biotechnology — Price Impact (10-K) by Year
Biotechnology — Price Impact (10-K) (%)
Danaher Biotechnology — Price Impact (10-K): 2.0% in FY2025, down 0.5 pts from a year earlier.
Latest, FY2025
2.0%
Period ended Dec 31, 2025
Change on a year earlier
-0.5 pts
2.5% in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Where the FY2025 figure comes from
“Price increases in the segment contributed 2.0% to sales growth on a year-over-year basis during 2025 as compared with 2024 and are reflected as a component of core sales above.”
Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Reported in Danaher SEC Form 10-K (Item 7 MD&A — Biotechnology).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biotechnology — Price Impact (10-K) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.0% | -0.5 pts | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 2.5% | -2.0 pts | Danaher SEC 10-K (FY2024, filed 2025-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 4.5% | +0.5 pts | Danaher SEC 10-K (FY2023, filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 4.0% | – | Danaher SEC 10-K (FY2022, filed 2023-02-22) ↗ |
Cite this data
StockData. (2026). Danaher Biotechnology — Price Impact (10-K) (%), annual FY2022–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-price-impact-biotech
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.